LIC MF Healthcare Fund Direct Growth
Equity
Direct
Sector - Healthcare
NAV as on 19-11-2024
₹ 31.41
▲0.6%
1D
Inception Returns
22.1%
/yr
About LIC MF Healthcare Fund Direct Growth
LIC MF Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 February, 2019. The fund is managed by Karan Doshi. The fund could potentially beat inflation in the long-run.
Key Parameters
- LIC MF Healthcare Fund Direct Growth has ₹81 Cr worth of assets under management (AUM) as on Oct 2024 and is less than category average.
- The fund has an expense ratio 1.2.
Returns
LIC MF Healthcare Fund Direct Growth has given a CAGR return of 22.13% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 45.20%, 17.26% and 24.41% respectively.
Holdings
LIC MF Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Piramal Pharma Ltd, Artemis Medicare Services Ltd Ordinary Shares, Torrent Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of LIC MF Healthcare Fund Direct Growth
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 200.00. LIC MF Healthcare Fund Direct Growth has no lock in period.
Historical NAV & Returns
Annualised
▲
▼
91 people have invested ₹ 5L in LIC MF Healthcare Fund Direct Growth in the last three months
INDmoney Rank for LIC MF Healthcare Fund Direct Growth
Powered by IND quant engine
IND ranking is not available for this fund.
Beats FD returns for both 3Y & 5Y duration
5Y returns in the bottom 25% of the category
3Y returns in the bottom 25% of the category
LIC MF Healthcare Fund Direct Growth Overview
| Expense ratio | 1.21% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹81 Cr |
| Inception Date | 28 February, 2019 |
| Min Lumpsum/SIP | ₹5000/₹200 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 414.8% |
| STCG | Redeeming before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (19-Nov-24)
Fund Distribution
as on (31-Oct-24)
Large cap
36.9%
Small cap
32.5%
Mid cap
23.6%
Sector Allocation
Health
97%
Basic Materials
3%
All changes are between Aug'24 and Oct'24
- This fund’s returns stands at 1.98% whereas the fund’s underlying benchmark Nifty 500 returns stands at -6.52% as on Oct'24
- This fund outperformed Nifty 500 by 8.50% in Oct'24
- AUM of the fund stands at 75 Cr as of Oct'24
- AUM has remained same between Oct'24 and Sep'24
Top Stocks bought last month
Syngene International Ltd's allocation increased from 2.11% to 3.64%
Neuland Laboratories Limited's allocation increased from 2.21% to 3.64%
Suven Pharmaceuticals Ltd's allocation increased from 3.55% to 4.27%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 11.4 % to 10.15 %
Piramal Pharma Ltd's allocation decreased from 7.76 % to 7.55 %
Artemis Medicare Services Ltd Ordinary Shares's allocation decreased from 6.06 % to 5.91 %
Small Cap allocation has gone up from 31.4% to 32.5%
Mid Cap allocation has gone up from 22.7% to 23.6%
Large Cap allocation has gone down from 40.7% to 36.9%
Cash allocation has gone up from 3.1% to 3.4%
Top 2 Sectors in October were Health, Basic Materials
Oct'24
Health
97%
Basic Materials
3%
Sep'24
Health
97%
Basic Materials
3%
See all
Top Growth Drivers | 1M Return |
|---|---|
 Piramal Pharma Ltd | 9.9% |
 Neuland Laboratories Ltd | 9.3% |
 Suven Pharmaceuticals Ltd | 0.2% |
Loading...
We are taking more time than usual
Karan Doshi
Fund Manager of LIC MF Healthcare Fund Direct Growth, since 31 July 2023
Top funds managed
Fund House
LIC Mutual Fund Asset Management Limited
Total Schemes
Total AUM
₹27.84K Cr
as on 31-Oct-2024
Address
LIC Mutual Fund Asset Management Limited,4th Floor, Industrial Assurance Building,,Opp. Churchgate Station,
Phone
+91022-66016000
Website
licmfamc@licmutual.com
Mutual Fund Insights
Over the last 6 months, this fund has experienced a 29.9% growth in AUM moving from 62.26 Cr to 80.86 Cr.
In the last 3 years, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 24.29% return, outperforming this fund by 7.03% per annum.
In the last 1 year, HDFC Pharma and Healthcare Fund Direct Growth has given 52.89% return, outperforming this fund by 7.69%.
In the last 5 years, DSP Healthcare Fund Direct Growth has given 32.68% return, outperforming this fund by 8.27% per annum.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 1.21% which is lower than the category average expense ratio of 1.39%.
LIC MF Healthcare Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 22.13% since inception which is less than its category average return of 24.96%
Fund Allocations
This fund has an allocation of 96.61% in Equity, 0% in Debt and 3.39% in Cash related instruments
AUM size ₹81 Cr
This fund has AUM of ₹81 Cr which is less than its category average of ₹ 2001 Cr
Expense Ratio 1.21%
This fund has an expense ratio of 1.21% which is less than its category average expense ratio of 1.33%
Frequently Asked Questions for LIC MF Healthcare Fund Direct Growth
The current NAV of LIC MF Healthcare Fund Direct Growth is ₹31.41 as on 19-Nov-2024.
Existing (Absolute + CAGR) as on 19-Nov-2024.
LIC MF Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -3.29% | -3.29% |
6 Month Returns | 20.83% | 20.83% |
1 Year Returns | 45.2% | 45.2% |
3 Years Returns | 61.24% | 17.26% |
5 Years Returns | 198.01% | 24.41% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
1.21% as on October 2024
₹81 Cr as on October 2024
Sun Pharmaceuticals Industries Ltd(10.15%), Piramal Pharma Ltd(7.55%), Artemis Medicare Services Ltd Ordinary Shares(5.91%), Torrent Pharmaceuticals Ltd(4.91%), Glenmark Pharmaceuticals Ltd(4.88%) as on October 2024
The alpha ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
LIC MF Healthcare Fund Direct Growth | 6.18 | -1.56 | -0.45 |
As on October 2024
The alpha for LIC MF Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
LIC MF Healthcare Fund Direct Growth | 0.89 | 0.93 | 0.92 |
As on October 2024
The Beta for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
LIC MF Healthcare Fund Direct Growth | 3.33 | 0.81 | 1.05 |
As on October 2024
The sharpe ratio for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
LIC MF Healthcare Fund Direct Growth | 13.42 | 15.29 | 18.37 |
As on October 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.44 as on October 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Karan Doshi is the fund manager of LIC MF Healthcare Fund Direct Growth
The Exit load of LIC MF Healthcare Fund Direct Growth is 1%